Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
52.71
-2.09 (-3.81%)
Mar 31, 2025, 1:17 PM EDT - Market open
Rhythm Pharmaceuticals Revenue
In the year 2024, Rhythm Pharmaceuticals had annual revenue of $130.13M with 68.06% growth. Rhythm Pharmaceuticals had revenue of $41.83M in the quarter ending December 31, 2024, with 72.61% growth.
Revenue (ttm)
$130.13M
Revenue Growth
+68.06%
P/S Ratio
25.69
Revenue / Employee
$459,809
Employees
283
Market Cap
3.33B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
RYTM News
- 10 days ago - Rhythm Pharmaceuticals Reacquires Licensing Rights to IMCIVREE® (setmelanotide) in China with Termination of Agreement with RareStone Ltd. - GlobeNewsWire
- 11 days ago - Rhythm Pharmaceuticals Announces Orphan Drug Designation Granted to Setmelanotide for Treatment of Hypothalamic Obesity in Japan - GlobeNewsWire
- 13 days ago - Rhythm Pharmaceuticals and Raymond A. Wood Foundation Announce Research Collaboration - GlobeNewsWire
- 4 weeks ago - Rhythm Pharmaceuticals, Inc. (RYTM) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update - GlobeNewsWire
- 4 weeks ago - Rhythm Pharmaceuticals: Buying This Rare Genetic Obesity Maven - Seeking Alpha
- 6 weeks ago - Rhythm Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on Wednesday, February 26, 2025 - GlobeNewsWire
- 2 months ago - Rhythm Pharmaceuticals Announces Preliminary Fourth Quarter and Full Year 2024 Net Product Revenues, Pipeline Advancements and Upcoming Milestones - GlobeNewsWire